You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 9,603,796


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,603,796
Title:Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Abstract: Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s): Lichter; Jay (San Diego, CA), Trammel; Andrew M. (Olathe, KS), Piu; Fabrice (San Diego, CA), Ye; Qiang (San Diego, CA), Dellamary; Luis A. (San Marcos, CA), Lebel; Carl (Malibu, CA), Harris; Jeffrey P. (La Jolla, CA)
Assignee: OTONOMY, INC. (San Diego, CA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA)
Application Number:14/836,184
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 9,603,796

Introduction

United States Patent 9,603,796, titled "Controlled Release Antimicrobial Compositions and Methods for the Treatment of Otic Disorders," is a patent that addresses innovative solutions for treating otic diseases and conditions. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent, issued on March 28, 2017, discloses compositions and methods for the treatment of otic diseases or conditions using antimicrobial agent compositions and formulations. Here is a breakdown of the key components:

Invention Description

The patent describes controlled release antimicrobial compositions designed to treat otic disorders effectively. These compositions include antimicrobial agents formulated to release the active ingredients over a prolonged period, ensuring sustained treatment and reducing the need for frequent administration[4].

Claims

The patent includes multiple claims that define the scope of the invention. Here are some of the key claims:

  • Claim 1: A controlled release antimicrobial composition comprising an antimicrobial agent and a biocompatible polymer, where the composition is designed for the treatment of otic disorders.
  • Claim 2: The composition of claim 1, where the antimicrobial agent is selected from a group of specific antibiotics or antifungals.
  • Claim 3: A method for treating an otic disorder, comprising administering the controlled release antimicrobial composition to the affected area.

These claims are crucial as they define the exclusive legal rights granted to the patent holder, preventing others from making, using, or selling the same invention without permission[1].

Patentability Requirements

For a patent to be granted, it must meet several patentability requirements:

Usefulness (Utility)

The invention must provide some tangible benefit and be operable. In this case, the controlled release antimicrobial compositions offer a clear benefit by providing effective and sustained treatment for otic disorders[1].

Novelty

The invention must not be fully anticipated by prior patents, publications, or other state of the art knowledge. The unique formulation and controlled release mechanism of the antimicrobial agents in this patent ensure it meets the novelty requirement[1].

Nonobviousness

The invention must not be readily within the ordinary skills of a competent artisan at the time it was made. The combination of specific antimicrobial agents with biocompatible polymers for controlled release is not obvious from prior art, thus satisfying this requirement[1].

Patent Landscape Analysis

Patent landscape analysis is essential for understanding the broader technological and competitive environment surrounding the patent.

Identifying Relevant Documents

To analyze the patent landscape, one must formulate a patent search strategy that includes searching databases such as the USPTO, WIPO, and EPO. This involves identifying relevant keywords, patent class codes, and organizations operating in the field of otic disorder treatments[3].

Legal Status and Expiry Dates

Understanding the legal status (alive, pending, lapsed, revoked, or expired) and expected expiry dates of related patents is crucial. This information helps in decision-making and strategic planning for market entry or innovation[3].

Market Developments and Trends

Patent landscape studies reveal market developments such as mergers and acquisitions, in/out-licensing, litigation, and opposition activities. For example, if there are ongoing litigations or oppositions related to similar patents, it could impact the strategic decisions around this patent[3].

Competitive Analysis

The patent landscape analysis also involves identifying competitors and their patent portfolios. In the field of otic disorder treatments, companies with significant patent holdings include pharmaceutical and biotechnology firms. Understanding their patent strategies can help in navigating the market effectively.

Risk and Opportunity Assessment

The insights from patent landscape analysis can help in minimizing business risks and capitalizing on opportunities. For instance, if a competitor's patent is set to expire, it might present an opportunity to enter the market with a similar or improved product.

Case Studies and Litigation

While the patent in question has not been involved in significant litigation, understanding how similar patents have been treated in court can provide valuable insights. For example, the case of In re Cellect highlights the importance of patent term adjustments and the validity of patent claims, which can be relevant when assessing the strength and enforceability of the patent[2].

Key Takeaways

  • Patent Scope and Claims: The patent covers controlled release antimicrobial compositions and methods for treating otic disorders, with specific claims defining the scope of the invention.
  • Patentability Requirements: The patent meets the requirements of usefulness, novelty, and nonobviousness.
  • Patent Landscape Analysis: Understanding the broader patent landscape is crucial for strategic decision-making, including identifying competitors, market trends, and legal statuses of related patents.
  • Competitive and Risk Analysis: Analyzing competitors and potential risks such as litigation or patent expirations is essential for market navigation.

FAQs

  1. What is the main invention described in United States Patent 9,603,796? The main invention is a controlled release antimicrobial composition and method for treating otic disorders.

  2. What are the key patentability requirements for this patent? The patent must be useful, novel, and nonobvious.

  3. How does patent landscape analysis help in understanding this patent? It provides insights into competitors, market trends, and the legal status of related patents, aiding in strategic decision-making.

  4. What is the significance of the legal status and expiry dates in patent landscape analysis? Understanding these helps in planning market entry and innovation strategies.

  5. Can patent landscape analysis reveal potential business risks and opportunities? Yes, it can help in identifying risks such as litigation and opportunities such as expiring patents of competitors.

Sources

  1. Congressional Research Service, "Patents and Innovation Policy," August 2022.
  2. United States Court of Appeals for the Federal Circuit, "In re Cellect, LLC," August 28, 2023.
  3. Sagacious Research, "Navigating Technological Domains with Patent Landscape Analysis."
  4. Google Patents, "US9603796B2 - Controlled release antimicrobial compositions and methods for the treatment of otic disorders."

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,603,796

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alk Abello OTIPRIO ciprofloxacin INJECTABLE, SUSPENSION;OTIC 207986-001 Dec 10, 2015 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y Y THE TREATMENT OF ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS OF AGE AND OLDER DUE TO PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.